Article
Molecular Basis of Pancreatic Neuroendocrine Tumors
14 Oct 2024
Abstract excerpt
Pancreatic neuroendocrine tumors (NETs) are rare well-differentiated neoplasms with limited therapeutic options and unknown cells of origin. The current classification of pancreatic neuroendocrine tumors is based on proliferative grading, and guides therapeutic strategies, however, tumors within grades exhibit profound heterogeneity in clinical manifestation and outcome. Manifold studies have highlighted...
Topics
Join the communities discussing this publication.
